vs
Side-by-side financial comparison of Insulet Corporation (PODD) and RANGE RESOURCES CORP (RRC). Click either name above to swap in a different company.
RANGE RESOURCES CORP is the larger business by last-quarter revenue ($786.9M vs $783.7M, roughly 1.0× Insulet Corporation). RANGE RESOURCES CORP runs the higher net margin — 22.8% vs 13.0%, a 9.8% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs 18.0%). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs 14.6%).
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
Range Resources Corporation is a natural gas exploration and production company, the headquartered is in Fort Worth, Texas. It operates in the Marcellus Formation, where it is the largest land owners.
PODD vs RRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $783.7M | $786.9M |
| Net Profit | $101.6M | $179.1M |
| Gross Margin | 72.6% | 94.5% |
| Operating Margin | 18.7% | — |
| Net Margin | 13.0% | 22.8% |
| Revenue YoY | 31.2% | 18.0% |
| Net Profit YoY | 0.9% | 88.8% |
| EPS (diluted) | $1.42 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $783.7M | $786.9M | ||
| Q3 25 | $706.3M | $655.3M | ||
| Q2 25 | $649.1M | $699.6M | ||
| Q1 25 | $569.0M | $846.3M | ||
| Q4 24 | $597.5M | $667.0M | ||
| Q3 24 | $543.9M | $567.9M | ||
| Q2 24 | $488.5M | $513.2M | ||
| Q1 24 | $441.7M | $598.8M |
| Q4 25 | $101.6M | $179.1M | ||
| Q3 25 | $87.6M | $144.3M | ||
| Q2 25 | $22.5M | $237.6M | ||
| Q1 25 | $35.4M | $97.1M | ||
| Q4 24 | $100.7M | $94.8M | ||
| Q3 24 | $77.5M | $50.7M | ||
| Q2 24 | $188.6M | $28.7M | ||
| Q1 24 | $51.5M | $92.1M |
| Q4 25 | 72.6% | 94.5% | ||
| Q3 25 | 72.2% | 92.5% | ||
| Q2 25 | 69.7% | 95.0% | ||
| Q1 25 | 71.9% | 93.1% | ||
| Q4 24 | 72.1% | 93.7% | ||
| Q3 24 | 69.3% | 94.3% | ||
| Q2 24 | 67.7% | 93.4% | ||
| Q1 24 | 69.5% | 94.7% |
| Q4 25 | 18.7% | — | ||
| Q3 25 | 16.7% | — | ||
| Q2 25 | 18.7% | — | ||
| Q1 25 | 15.6% | — | ||
| Q4 24 | 18.3% | — | ||
| Q3 24 | 16.2% | — | ||
| Q2 24 | 11.2% | — | ||
| Q1 24 | 12.9% | — |
| Q4 25 | 13.0% | 22.8% | ||
| Q3 25 | 12.4% | 22.0% | ||
| Q2 25 | 3.5% | 34.0% | ||
| Q1 25 | 6.2% | 11.5% | ||
| Q4 24 | 16.9% | 14.2% | ||
| Q3 24 | 14.2% | 8.9% | ||
| Q2 24 | 38.6% | 5.6% | ||
| Q1 24 | 11.7% | 15.4% |
| Q4 25 | $1.42 | $0.75 | ||
| Q3 25 | $1.24 | $0.60 | ||
| Q2 25 | $0.32 | $0.99 | ||
| Q1 25 | $0.50 | $0.40 | ||
| Q4 24 | $1.38 | $0.38 | ||
| Q3 24 | $1.08 | $0.21 | ||
| Q2 24 | $2.59 | $0.12 | ||
| Q1 24 | $0.73 | $0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $204.0K |
| Total DebtLower is stronger | $930.8M | $1.2B |
| Stockholders' EquityBook value | $1.5B | $4.3B |
| Total Assets | $3.2B | $7.4B |
| Debt / EquityLower = less leverage | 0.61× | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $204.0K | ||
| Q3 25 | — | $175.0K | ||
| Q2 25 | — | $134.0K | ||
| Q1 25 | — | $344.6M | ||
| Q4 24 | — | $304.5M | ||
| Q3 24 | — | $277.4M | ||
| Q2 24 | — | $251.1M | ||
| Q1 24 | — | $343.1M |
| Q4 25 | $930.8M | $1.2B | ||
| Q3 25 | $934.9M | $1.2B | ||
| Q2 25 | $939.0M | $1.2B | ||
| Q1 25 | $1.6B | $1.7B | ||
| Q4 24 | $1.3B | $1.7B | ||
| Q3 24 | $1.4B | $1.7B | ||
| Q2 24 | $1.4B | $1.7B | ||
| Q1 24 | $1.4B | $1.8B |
| Q4 25 | $1.5B | $4.3B | ||
| Q3 25 | $1.4B | $4.2B | ||
| Q2 25 | $1.5B | $4.1B | ||
| Q1 25 | $1.3B | $3.9B | ||
| Q4 24 | $1.2B | $3.9B | ||
| Q3 24 | $1.1B | $3.9B | ||
| Q2 24 | $998.4M | $3.9B | ||
| Q1 24 | $790.7M | $3.8B |
| Q4 25 | $3.2B | $7.4B | ||
| Q3 25 | $3.0B | $7.2B | ||
| Q2 25 | $3.5B | $7.1B | ||
| Q1 25 | $3.5B | $7.4B | ||
| Q4 24 | $3.1B | $7.3B | ||
| Q3 24 | $3.0B | $7.2B | ||
| Q2 24 | $2.9B | $7.3B | ||
| Q1 24 | $2.6B | $7.4B |
| Q4 25 | 0.61× | 0.28× | ||
| Q3 25 | 0.68× | 0.29× | ||
| Q2 25 | 0.64× | 0.29× | ||
| Q1 25 | 1.21× | 0.43× | ||
| Q4 24 | 1.07× | 0.43× | ||
| Q3 24 | 1.21× | 0.44× | ||
| Q2 24 | 1.36× | 0.44× | ||
| Q1 24 | 1.72× | 0.46× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.3M | $257.5M |
| Free Cash FlowOCF − Capex | $48.2M | — |
| FCF MarginFCF / Revenue | 6.2% | — |
| Capex IntensityCapex / Revenue | 17.2% | — |
| Cash ConversionOCF / Net Profit | 1.80× | 1.44× |
| TTM Free Cash FlowTrailing 4 quarters | $377.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.3M | $257.5M | ||
| Q3 25 | $125.7M | $247.5M | ||
| Q2 25 | $196.5M | $336.2M | ||
| Q1 25 | $63.8M | $330.1M | ||
| Q4 24 | $147.7M | $217.9M | ||
| Q3 24 | $98.5M | $245.9M | ||
| Q2 24 | $96.5M | $148.8M | ||
| Q1 24 | $87.6M | $331.9M |
| Q4 25 | $48.2M | — | ||
| Q3 25 | $100.1M | — | ||
| Q2 25 | $177.9M | — | ||
| Q1 25 | $51.5M | — | ||
| Q4 24 | $94.1M | — | ||
| Q3 24 | $71.8M | — | ||
| Q2 24 | $74.0M | — | ||
| Q1 24 | $65.5M | — |
| Q4 25 | 6.2% | — | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | 27.4% | — | ||
| Q1 25 | 9.1% | — | ||
| Q4 24 | 15.7% | — | ||
| Q3 24 | 13.2% | — | ||
| Q2 24 | 15.1% | — | ||
| Q1 24 | 14.8% | — |
| Q4 25 | 17.2% | — | ||
| Q3 25 | 3.6% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | 5.0% | — |
| Q4 25 | 1.80× | 1.44× | ||
| Q3 25 | 1.43× | 1.72× | ||
| Q2 25 | 8.73× | 1.42× | ||
| Q1 25 | 1.80× | 3.40× | ||
| Q4 24 | 1.47× | 2.30× | ||
| Q3 24 | 1.27× | 4.85× | ||
| Q2 24 | 0.51× | 5.18× | ||
| Q1 24 | 1.70× | 3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
